Australian cyclist Michael Rogers has been provisionally suspended by the Union Cycliste Internationale (UCI) after testing positive for the banned substance clenbuterol at October's Japan Cup Cycle Road Race, media reported Thursday.
The world's governing body for cycling, the UCI, said the decision to provisionally suspend Rogers would remain in force until a hearing panel convened by Cycling Australia determines whether he has committed an anti-doping rule violation, Xinhua reported citing a UCI statement.
"Rogers has the right to request and attend the analysis of his B sample," the UCI statement said.
According to the UCI, a report from a laboratory in Tokyo accredited by the World Anti-Doping Agency (WADA) showed an adverse analytical finding of clenbuterol in a urine sample collected from Rogers in a test during the Japan Cup Cycle Road Race Oct 20.
But Rogers denies deliberate doping, fearing a contaminated food source is the reason behind the test result, media reports said.
The 33-year-old Saxo-Tinkoff rider is a three-time World Time-Trial Champion, winning consecutively in 2003, 2004 and 2005.
"Michael Rogers immediately informed Saxo-Tinkoff's management about the notification from the UCI," the cycling team said in a statement.
"The Australian explained to the team management that he never ingested the substance knowingly nor deliberately and fears that the adverse analytical finding origins from a contaminated food source."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
